Literature DB >> 4328935

A specific, reversible, macromolecular inhibitor of hepatic glucagon responsive adenyl cyclase.

M W Bitensky, R E Gorman, A H Neufeld, R King.   

Abstract

Mesh：

Substances：

Year:  1971        PMID： 4328935     DOI： 10.1210/endo-89-5-1242

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  5 in total

1.  A temperature-sensitive change in the energy of activation of hormone-stimulated hepatic adenylyl cyclase.

Authors:  P W Kreiner; J J Keirns; M W Bitensky
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

2.  Reduced sensitivity of the hepatic adenylate cyclase-cyclic AMP system to glucagon during sustained hormonal stimulation.

Authors:  F R DeRubertis; P Craven
Journal:  J Clin Invest       Date:  1976-02       Impact factor: 14.808

3.  Evidence for delayed development of the glucagon receptor of adenylate cyclase in the fetal and neonatal rat heart.

Authors:  C M Clark; B Beatty; D O Allen
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

4.  Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.

Authors:  M J Droller; S M Wolfe
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

5.  The effects of glucagon and insulin on adenosine 3':5'-cyclic monophosphate concentrations in an organ culture of mature rat liver.

Authors:  K Siddle; B Kane-Maguire; A K Campbell
Journal:  Biochem J       Date:  1973-04       Impact factor: 3.857
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.